Maloney urges OMB to act on rule to restrict child and teen tanning bed use
WASHINGTON – Chairwoman of the Congressional Skin Cancer Caucus Congresswoman Carolyn B. Maloney (D-NY) this week joined Congressman Ted Lieu and 16 other House members in urging the Office of Management and Budget (OMB) to take action on a proposed FDA rule that would restrict indoor tanning by children under 18. Maloney first urged the FDA to adopt such a rule in a letter to then FDA Commissioner Margaret Hamburg in June 2014. In April 2015, Maloney again pressed the agency in a letter to Acting FDA Commissioner Dr. Stephen Ostroff.
“Thanks to the FDA, every tanning bed now has a warning label explaining the risks to those under 18,” said Maloney. “That’s an important first step. Yet given the known health risks tanning beds present, especially to minors, along with the steep climb in skin cancer rates we’ve seen over the last two decades, children really shouldn’t be allowed to use these devices. Over the past year, I've pressed the Administration to enact tougher restrictions on the use of tanning beds by minors, and I’m pleased the FDA appears to be moving in this direction. Now we are urging OMB to act as quickly possible to move forward with these important protections.”
Maloney led the fight to reclassify tanning beds as Class II medical devices. Under the new classification, the FDA now requires black box warning labels on all tanning beds, indicating that the products should not be used by those under the age of 18. Manufacturers are also required to include additional warnings in their marketing materials and show that their products meet performance testing requirements. Maloney’s TAN Act, which passed as part of the FDA Amendments Act of 2007, required the FDA to study the efficacy of warning labels for tanning beds and began the process that led to this reclassification of UV tanning lamps as Class II medical devices, which was finalized in May 2014.
In 2013, Maloney formed the Congressional Skin Cancer Caucus, which she co-chairs with Reps. Charles Dent (R-PA), Jim Cooper (D-TN), and David Joyce (R-OH), in an effort to bring greater attention on Capitol Hill and to the public at large about this public health crisis.